Top Stories
Popular weight-loss drugs may play surprising role in cancer outcomes
GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key clinical trials are needed.
Read more at FOX ›
Read the full story at
FOX
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX, and the link opens their page. This page exists so readers can find, share, and discuss the story here.